TransMedics - U.S. group specializing in organ transplant technologies - chose the biomedical district of Mirandola, in the province of Modena, as its European hub. The new facility will be dedicated to the development and production of the Organ Care System (OCS), a portable perfusion technology approved by the Food and Drug Administration (FDA) for lung, heart, and liver transplants.
The investment was presented during a press conference in Mirandola on April 16, 2025, with the participation of the Vice President of the Emilia-Romagna Region, Vincenzo Colla. Waleed Hassanein, founder and president of TransMedics, emphasized that Emilia-Romagna has been chosen for its excellence and expertise in the biomedical sector, deeming it an ideal location to attract talents and foster an ecosystem where medical expertise and cutting-edge technologies converge to generate innovation.
The full-scale investment plans for the hiring of approximately 50-100 highly qualified employees. These will primarily be engineers for development and design activities, with additional personnel for subsequent production. The center of excellence will be located in an area spanning 9,000 square meters. Concurrently, a temporary structure adjacent to this area has been leased, which will enable the initial hiring of the local team in the coming months.
Link: www.transmedics.com
Source: Il Resto del Carlino (16/04/2025), Municipality of Mirandola (16/04/2025)
